S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7119 +0.14%
AFTER HRS · 18:25 ET
Market ClerkRecap
Wed Oct 21 · after hours2 signals today106 insider buys this week · $305.5MCIRO short report next: Oct 31The week ahead

VNRX

VOLITIONRX LTD
NYSE · HEALTH CARE · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
0.17
−0.00 −2.88%
USD · close Oct 21

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $2.3MP/E —DIV YIELD —FCF YIELD -869.06%REV TTM $2.5M +86.3%NET INCOME −$25.6MNET DEBT $4.3M52W 0.17 – 9.00SEC XBRL · TTM TO Invalid Date

What VNRX had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Sep 25Unregistered share saleSep 22open on EDGAR ↗
Sep 15Unregistered share saleSep 9open on EDGAR ↗
Sep 14Other eventSep 11open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch VNRX. Know when insiders buy.
One email the day a filing lands. Free.